Multiple Sclerosis and Related Disorders

Papers
(The H4-Index of Multiple Sclerosis and Related Disorders is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Test-retest reliability of the Swedish version of the Modified Fatigue Impact Scale in people with mild to moderate multiple sclerosis73
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis59
Characteristics of Patients with Newly Diagnosed Multiple Sclerosis: A Five-Year Study at Benghazi Medical Center, Benghazi, Libya58
Psychometric measurement properties and reference values of the six-spot step test, the six-minute walk test, the 25-foot walk test, and the 12-item multiple sclerosis walking scale in people with mul58
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study48
Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression46
Influence of Cigarette, and Waterpipe Smoking, Alcohol, and Drug Consumption on the Occurrence of Late-Onset Multiple Sclerosis46
Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies46
EDSS and Infratentorial White Matter Lesion Volume are Considered Predictors of Fatigue Severity in RRMS46
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina46
A one year follow of patients with multiple sclerosis during COVID-19 pandemic: A cross-sectional study in Qom province, Iran41
Sexual problems in MS: Sex differences and their impact on quality of life41
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America40
Diagnosing ‘transition’ to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians39
“It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis39
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis39
Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease37
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)36
The effects of bupropion on sexual dysfunction in female patients with multiple sclerosis: A double-blind randomized clinical trial36
Involvement Peripheral Nerve System in Multiple Sclerosis36
Effects of constraint induced movement therapy in patients with multiple sclerosis: A systematic review35
The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study35
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets34
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis34
The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia34
Index of cardiac-electrophysiological balance in relapsing–remitting multiple sclerosis patients treated with fingolimod34
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran34
Clinical and imaging features of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease34
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy33
Trait mindfulness, emotion dysregulation, and depression in individuals with multiple sclerosis33
Characteristics of recurrence risk perception and coping strategies in patients with neuromyelitis optica spectrum disorder: A qualitative study33
Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesis32
Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study32
0.056504964828491